id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-D-1086-0002,FDA,FDA-2012-D-1086,Guidance  for Industry; Labeling and Effectiveness Testing; Sunscreen Drug Products for Over-the-Counter Human Use; Small Entity Compliance Guide,Other,Guidance,2012-12-06T05:00:00Z,2012,12,2012-12-06T05:00:00Z,,2024-11-12T05:10:44Z,,1,0,0900006481181139
FDA-2012-D-1086-0001,FDA,FDA-2012-D-1086,Compliance Guidancesfor Small Business Entities; Labeling and Effectiveness Testing; Sunscreen Drug Products for Over-the-Counter Human Use; Availability,Notice,Notice of Availability,2012-12-06T05:00:00Z,2012,12,2012-12-06T05:00:00Z,,2012-12-06T17:34:56Z,2012-29462,0,0,0900006481180cf4